Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-19
2006-12-19
Kemmerer, Elizabeth (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200
Reexamination Certificate
active
07151083
ABSTRACT:
The present invention relates to the use of gonadotrophins in the induction of folliculogenesis in anovulatory women. In particular, it relates to the use of LH (or an equivalent dosage of hCG) in the production of a medicament for inducing folliculogenesis in anovulatory women at a specified daily doses. In certain embodiments, LH may be used in conjunction with FSH.
REFERENCES:
patent: 4845077 (1989-07-01), Hodgen
patent: 4959354 (1990-09-01), Barbetti
patent: 5162306 (1992-11-01), Donaldson et al.
patent: 5610138 (1997-03-01), Jacobs
patent: 6660717 (2003-12-01), Rose et al.
patent: 0193277 (1986-09-01), None
patent: WO 93/13799 (1993-07-01), None
Garcia-Campayo and Boime. Novel recombinant gonadotropins. Trends in Endocrinol & Metab. 2001; 12(2):72-77.
Breckwoldt et al. Induction of ovulationin noncycling and hypophysectomized rhesus monkeys with various human gonadotropins. 1971. Fertil. Steril, 22(7): 451-455.
XP-002135914—Recombinant human luteinising hormone: an effective new gonadotropin preparation,The Lancet, 344:334-335 (1994).
Sullivan et al., Ovarian response in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation,Journal of Clinical Endocrinology and Metabolism, 84:(1)228-232 (1999).
Hillier, Review—Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis,Human Reproduction, 9(2):188-191 (1994).
The European recombinant human LH study group, Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study,Journal of Clinical Endocrinology and Metabolism, 83(5)1507-1514 (1998).
Tapanainen et al., Induction of ovarian follicle luteinization by recombinant follicle-stimulating hormone,Endocrinology133(6):2875-2880 (1993).
D'Alessandro et al., Some effects of adding p-LH in defined amounts to purified p-FSH to modify FSH/LH ratios during the superovulatory treatment of anestrous ewes,Animal Reproduction Science, 47:91-98 (1997).
Franks Stephen
Hillier Stephen
Applied Research Systems ARS Holding N.V.
Borgeest Christina
Browdy and Neimark PLLC
Kemmerer Elizabeth
LandOfFree
Luteinizing hormone and follicle stimulating hormone for use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Luteinizing hormone and follicle stimulating hormone for use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luteinizing hormone and follicle stimulating hormone for use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3712674